ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

AUA Leadership Program Announces 2025 Class

BALTIMORE, April 03, 2025 (GLOBE NEWSWIRE) -- The American Urological Association (AUA) announced today the newest members of the AUA Leadership Program. The 2025-2026 program marks the 11th Leadership Class, with 28 participants nationwide.

“The AUA understands that cultivating and nurturing leaders is critical for the future of our organization — and the future of our specialty,” said AUA President Stephen Y. Nakada, MD. “The Leadership Program has played a vital role in shaping urology’s leaders of tomorrow, and we are proud to add such an exceptional group of individuals to this esteemed program.”

The AUA Leadership Program is a prestigious and long-standing initiative designed for urologists who have demonstrated leadership within organized medicine. This highly competitive program selects participants from each AUA Section for a year-long experience that includes a leadership training weekend, mentorship-driven group projects, engagement in the Annual Urology Advocacy Summit, networking opportunities at the AUA Annual Meeting and more.

AUA Secretary Dr. David Penson added, “This highly competitive program has produced more than 200 graduates since it was launched in 2004, and those graduates can now be found in leadership roles across organized urology, including the AUA Board of Directors, AUA Section leadership and subspecialty societies like the Endourological Society, ROCK Society, Society of Urologic Oncology and others. We have seen Leadership Program graduates accomplish amazing things, and I look forward to seeing the difference this new class is going to make.” 

Notable graduates of the Leadership Program include Eugene Rhee, MD, the incoming AUA president-elect; Robert Siemens, the current editor of The Journal of Urology®; and Kathleen Kobashi, the incoming editor of Urology Practice.

Congratulations to the 2025 class of the AUA Leadership Program:

Mid-Atlantic Section

  • Daniel Lee, MD
  • Matthew Meissner, MD
  • Krishnan Venkatesan, MD

New England Section

  • Jaime Cavallo, MD, MPHS
  • Matthew Mossanen, MD
  • Benjamin T. Ristau, MD

New York Section

  • Justin Han, MD
  • Katie Murray, DO, MS, FACS
  • Andrew Winer, MD

North Central Section

  • Denise Asafu-Adjei, MD, MPH
  • Bradley Gill, MD, MS
  • Nathan Grunewald, MD
  • Kevin Koo, MD, MPH, MPhil 

Northeastern Section

  • Vineet Agrawal, MD, MHA, FRCSEd, FEBU
  • Teresa Danforth, MD
  • Thomas Frye, DO

South Central Section

  • Marawan El Tayeb, MD
  • Ty Higuchi, MD, PhD
  • Michael Johnson, MD
  • Casey Kowalik, MD, FACS

Southeastern Section

  • Hans Arora, MD, PhD
  • Adam Baumgarten, MD
  • Lourdes Guerrios-Rivera, MD, MSc
  • Chad Ritch, MD, MBA, FACS

Western Section

  • Sudhir Isharwal, MD
  • Una Lee, MD
  • Brock O'Neil, MD
  • Sarah Psutka, MD, MS, FACS

 Learn more about the AUA Leadership Program at AUAnet.org/Leadership

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology and has nearly 26,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.

Attachment


Corey Del Bianco
American Urological Association
443-689-4033
cdelbianco@auanet.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.